COMBINATION_PRODUCT · Unmapped registry intervention
Microdevice
Find medicine records ·
Find other trials using this name
Clinical trial
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
NCT04399876
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
Design: INTERVENTIONAL · Status: ENROLLING BY INVITATION · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Radical Prostatectomyunresolved
Interventions
MicrodeviceCOMBINATION_PRODUCT
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04399876 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.